AVENUE THERAPEUTICS INC (ATXI)

US05360L3042 - Common Stock

0.13  0 (-3.42%)

After market: 0.132 +0 (+1.54%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
111.00K50.00KN/AN/AN/A
Operating Expenses
14.54M8.04M3.74M5.21M26.27M
Research and Development
10.36M2.70M1.25M2.87M23.19M
Selling, General, and Administrative Expenses
4.18M5.35M2.48M2.35M3.07M
Operating Income
-14.54M-8.04M-3.74M-5.21M-26.27M
Interest Income/Expense
-206.00K-1.14M10.00K60.00K360.00K
Other Income/Expense
4.26M5.58MN/AN/A0.00
Income Before Taxes
-10.49M-3.60M-3.73M-5.15M-25.91M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-10.38M-3.55M-3.73M-5.15M-25.91M
 
Per Share Data
EPS Diluted Total Ops
-0.98-1.63-3.29-4.68-24.67
Non GAAP EPS
-1.75N/AN/A-4.65-25.80
 
Statistics

All data in USD

Charts